- Target and mechanism assessment
- Whole-joint biology
- Translational relevance
- Preclinical-model review
- Human evidence
- Target engagement
- Pharmacodynamic strategy
- Translational gaps
- First-in-human rationale
- Tissue and biofluid strategy
Capabilities
Our capabilities cover the scientific, clinical, regulatory and strategic disciplines required to move an osteoarthritis programme from hypothesis to evidence and from evidence to value.